The results suggested that there was no significant association between the genetic variation of AMPD1 rs17602729, MTHFR C677T, and MTHFR A1298C and serum calcium levels in patients with RA receiving MTX therapy. The gene discussed is MTHFR; the disease is rheumatoid arthritis.